Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...

At close: November 8 at 4:00 PM EST ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

Relay Therapeutics Inc ( (RLAY)) has released its Q3 earnings. Here is a breakdown of the information Relay Therapeutics Inc presented to its investors. Relay Therapeutics Inc., a clinical-stage ...

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report), retaining the price target of $86.00. Silvan Tuerkcan has given his Buy ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

In a recent move, Carl Dambkowski, Chief Medical Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), sold a significant amount of company stock, totaling over... Apogee (NASDAQ ...

Two pioneering digital therapeutics (DTx) for addiction are available once again after their original developer Pear Therapeutics was dissolved last year. The AI effect in pharma commercial ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Vivo is reportedly gearing up to launch its latest S20 series this month in China, according to a recent leak by tipster Smart Pikachu. Following the success of the S19 series, the S20 lineup is ...

Melania Trump declined Jill Biden's invitation for tea at the White House as their husbands meet for the customary post-election lunch. Melania reportedly cited a scheduling conflict but sources ...